Kemnay Advisory Services Inc.
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1555283
New York, NY
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$106,482
+$39,914 QoQ
Shares Held
18,359
+116.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Kemnay Advisory Services Inc. holds $554,461 across 17 Drug Manufacturers - Specialty & Generic names. XERS ranks #1 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
18,359 | $106,482 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
6,869 | $99,600 | |
| 3 | PAHC |
Phibro Animal Health Corp
|
956 | $52,876 | |
| 4 | ALKS |
Alkermes plc.
|
1,361 | $48,124 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
507 | $38,455 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
1,463 | $30,371 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
977 | $29,778 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
457 | $23,622 |
All Filings in XERS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,482 | 18,359 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $66,568 | 8,480 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||